X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cadila Healthcare with ACTAVIS INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ACTAVIS (US) - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   ACTAVIS
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-16
ACTAVIS
Dec-14
CADILA HEALTHCARE/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs45417,503-   
Low Rs30510,676-   
Sales per share (Unadj.) Rs96.13,151.8-  
Earnings per share (Unadj.) Rs14.9-393.3-  
Cash flow per share (Unadj.) Rs17.8289.2-  
Dividends per share (Unadj.) Rs3.200-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs52.36,836.1-  
Shares outstanding (eoy) m1,023.74265.90-   
Bonus/Rights/Conversions FV5:1--  
Price / Sales ratio x3.94.5 88.3%   
Avg P/E ratio x25.5-35.8 -71.2%  
P/CF ratio (eoy) x21.348.7 43.7%  
Price / Book Value ratio x7.32.1 352.2%  
Dividend payout %21.50-   
Avg Mkt Cap Rs m388,4583,746,408 10.4%   
No. of employees `00015.421.6 71.5%   
Total wages/salary Rs m13,3170-   
Avg. sales/employee Rs Th6,371.138,799.0 16.4%   
Avg. wages/employee Rs Th862.40-   
Avg. net profit/employee Rs Th986.1-4,841.7 -20.4%   
INCOME DATA
Net Sales Rs m98,376838,058 11.7%  
Other income Rs m941-2,092 -45.0%   
Total revenues Rs m99,317835,966 11.9%   
Gross profit Rs m23,829107,660 22.1%  
Depreciation Rs m3,022181,470 1.7%   
Interest Rs m48626,434 1.8%   
Profit before tax Rs m21,262-102,335 -20.8%   
Minority Interest Rs m-3000-   
Prior Period Items Rs m50-   
Extraordinary Inc (Exp) Rs m-25-7,507 0.3%   
Tax Rs m5,716-5,261 -108.6%   
Profit after tax Rs m15,226-104,581 -14.6%  
Gross profit margin %24.212.8 188.6%  
Effective tax rate %26.95.1 522.9%   
Net profit margin %15.5-12.5 -124.0%  
BALANCE SHEET DATA
Current assets Rs m44,376441,549 10.1%   
Current liabilities Rs m34,071322,019 10.6%   
Net working cap to sales %10.514.3 73.4%  
Current ratio x1.31.4 95.0%  
Inventory Days Days5458 92.8%  
Debtors Days Days6266 94.1%  
Net fixed assets Rs m47,896102,335 46.8%   
Share capital Rs m1,0240-   
"Free" reserves Rs m48,7460-   
Net worth Rs m53,5191,817,717 2.9%   
Long term debt Rs m8,964952,519 0.9%   
Total assets Rs m100,1633,331,277 3.0%  
Interest coverage x44.7-2.9 -1,558.5%   
Debt to equity ratio x0.20.5 32.0%  
Sales to assets ratio x1.00.3 390.4%   
Return on assets %15.7-2.3 -668.7%  
Return on equity %28.4-5.8 -494.5%  
Return on capital %34.3-3.0 -1,139.0%  
Exports to sales %45.30-   
Imports to sales %5.90-   
Net fx Rs m35,8120-   
CASH FLOW
From Operations Rs m19,938143,911 13.9%  
From Investments Rs m-9,039-344,578 2.6%  
From Financial Activity Rs m-9,527193,603 -4.9%  
Net Cashflow Rs m1,372-7,064 -19.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 64.16 Rs / USD

Compare CADILA HEALTHCARE With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: AJANTA PHARMA  SUVEN LIFE  PANACEA BIOTECH  UNICHEM LAB  AUROBINDO PHARMA  



Today's Market

Infosys Woes, Insurance IPOs and Top Stocks in Action(Pre-Open)

On Monday, the share markets in India slumped in the final hours of trade and finished the day in red.The BSE Sensex closed lower by 266 points to end at 31,259.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 22, 2017 09:21 AM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS